Specific proteins in human cancer
Burtin, P.
Nouvelle Revue Francaise d'Hematologie 10(3): 335-338
1970
ISSN/ISBN: 0029-4810 PMID: 4318497 Document Number: 24685
Document emailed within 1 workday
Related Documents
Killingsworth, L.M.; Savory, J.; Heintges, M.G. 1974: Measurement of specific proteins in cancer: a brief review of selected methods Annals of Clinical and Laboratory Science 4(6): 462-470Schweighoffer, F.; Faure, M.; Fath, I.; Chevallier-Multon, M.C.; Apiou, F.; Dutrillaux, B.; Sturani, E.; Jacquet, M.; Tocque, B. 1993: Identification of a human guanine nucleotide-releasing factor (H-GRF55) specific for Ras proteins Oncogene 8(6): 1477-1485
Calvo, M.; Guzman, F.; Perez, E.; Segura, C.H.; Molano, A.; Patarroyo, M.E. 1991: Specific interactions of synthetic peptides derived from P. falciparum merozoite proteins with human red blood cells Peptide Research 4(6): 324-333
García-Tamayo, F.; Hashimoto-Yañez, B.; Kumate, J. 1980: Specific proteins and culture media proteins found in trophozoites of E. histolytica obtained by axenic cultivation Archivos de Investigacion Medica 11(1 Suppl): 159-162
Edson, C.M.; Cohen, L.K.; Henle, W.; Strominger, J.L. 1983: An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo Journal of Immunology 130(2): 919-924
Yasumoto, K.; Setoguchi, Y.; Kamei, M.; Kato, M.; Nomoto, K.; Murakami, H.; Hashizume, S. 1993: Cancer-specific binding of a mouse MAb vs. Candida krusei cytochrome c: an antigen recognized by a cancer-associated human MAb HB4C5 Human Antibodies and Hybridomas 4(4): 186-189
Shoji, M.; Kawamoto, S.; Sato, S.; Kamei, M.; Kato, M.; Hashizume, S.; Seki, K.; Yasumoto, K.; Nagashima, A.; Nakahashi, H. 1994: Specific reactivity of human monoclonal antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients Human Antibodies and Hybridomas 5(3-4): 116-122
Nakamura, R.; Saikawa, Y.; Hosokawa, S.; Fukuda, K.; Kumai, K.; Kubota, T.; Kitajima, M.; Kitagawa, Y. 2008: Development of 36 clones producing human monoclonal antibodies specific to cancer cells and their ability to inhibit cancer cell growth Anticancer Research 28(3a): 1651-1657
Spandidos, D.A.; Karaiossifidi, H.; Malliri, A.; Linardopoulos, S.; Vassilaros, S.; Tsikkinis, A.; Field, J.K. 1992: Expression of ras Rb1 and p53 proteins in human breast cancer Anticancer Research 12(1): 81-89
Streydio, C.; Lacka, K.; Swillens, S.; Vassart, G. 1988: The human pregnancy-specific beta 1-glycoprotein (PS beta G) and the carcinoembryonic antigen (CEA)-related proteins are members of the same multigene family Biochemical and Biophysical Research Communications 154(1): 130-137
Bernal, S.D.; Baylin, S.B.; Shaper, J.H.; Gazdar, A.F.; Chen, L.B. 1983: Cytoskeleton-associated proteins of human lung cancer cells Cancer Research 43(4): 1798-1808
Krasnov, G.S.; Khankin, S.L.; Bukurova, I.A.; Zatsepina, O.G.; Oparina, N.I.; Garbuz, D.G.; Ershov, A.N.; Mashkova, T.D.; Karpov, V.L.; Beresten', S.F. 2009: Proteomic expression analysis of human colorectal cancer: of soluble overexpressed proteins Molekuliarnaia Biologiia 43(4): 610-615
Celis, J.E.; Ratz, G.P.; Celis, A. 1987: Secreted proteins from normal and SV40 transformed human MRC-5 fibroblasts: toward establishing a database of human secreted proteins Leukemia 1(10): 707-717
Sarnecka-Keller, M. 1978: Proteins on the human body--clinical and diagnostic aspects. Synthesis and degradation of proteins in the human body Przeglad Lekarski 35(2): 311-316
Hori, T. 1986: Fragile sites on human chromosomes and cancer-specific chromosomal rearrangements Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 2): 667-676
Li, Q.; Morimoto, K.; Kobayashi, M.; Inagaki, H.; Katsumata, M.; Hirata, Y.; Hirata, K.; Suzuki, H.; Li, Y.J.; Wakayama, Y.; Kawada, T.; Park, B.J.; Ohira, T.; Matsui, N.; Kagawa, T.; Miyazaki, Y.; Krensky, A.M. 2008: Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins International Journal of Immunopathology and Pharmacology 21(1): 117-127
Hirtenlehne, K.; Pec, M.; Kubista, E.; Singer, C.F. 2002: Extracellular matrix proteins influence phenotype and cytokine expression in human breast cancer cell lines European Cytokine Network 13(2): 234-240
Dejardin, E.; Bonizzi, G.; Bellahcène, A.; Castronovo, V.; Merville, M.P.; Bours, V. 1995: Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells Oncogene 11(9): 1835-1841
Yoshino, I.; Peoples, G.E.; Goedegebuure, P.S.; Maziarz, R.; Eberlein, T.J. 1994: Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer Journal of Immunology 152(5): 2393-2400
Jefferis, R.; Butwell, A.J.; Clamp, J.R. 1975: Studies on human IgD myeloma proteins. Carbohydrate composition of intact proteins and some proteolytic fragments Clinical and Experimental Immunology 22(2): 311-315